Condition

Cataract (3)

Overall Status

Completed (3)

Sign in for free

Phase

phase 3 (2)

Sponsor

EyePoint Pharmaceuticals, Inc. (1)

ICON Bioscience Inc (1)

Salvat (1)

Collaborator

Intervention

clobetasol propionate (1)

dexamethasone (1)

dexycu (dexamethasone intraocular suspension) 9%. (1)

prednisolone (1)

vehicle (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (2)

Observational (1)

Cataract

Showing NaN - NaN of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Cataract Trial in United States (Clobetasol Propionate, Vehicle)

Completed

Cataract

Clobetasol Propionate
Vehicle

Sun City, Arizona
+17 more

Nov 30, 2022

DEXYCU 9% Retrospective Study 001

Completed

Cataract

DEXYCU (dexamethasone intraocular suspension) 9%.

Dothan, Alabama
+21 more

May 24, 2021

Cataract Trial in United States (Dexamethasone, Prednisolone)

Completed

Cataract

Glendora, California
+10 more

Jul 24, 2018